228 related articles for article (PubMed ID: 29100957)
1. Implications of farnesyltransferase and its inhibitors as a promising strategy for cancer therapy.
Klochkov SG; Neganova ME; Yarla NS; Parvathaneni M; Sharma B; Tarasov VV; Barreto G; Bachurin SO; Ashraf GM; Aliev G
Semin Cancer Biol; 2019 Jun; 56():128-134. PubMed ID: 29100957
[TBL] [Abstract][Full Text] [Related]
2. Farnesyltransferase inhibitor as anticancer agent.
Agrawal AG; Somani RR
Mini Rev Med Chem; 2009 Jun; 9(6):638-52. PubMed ID: 19519490
[TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitors.
Kurzrock R
Clin Adv Hematol Oncol; 2005 Mar; 3(3):161-2. PubMed ID: 16166986
[No Abstract] [Full Text] [Related]
4. Farnesyltransferase inhibitors as anticancer agents: current status.
Zhu K; Hamilton AD; Sebti SM
Curr Opin Investig Drugs; 2003 Dec; 4(12):1428-35. PubMed ID: 14763128
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein prenylation for cancer therapy.
Berndt N; Hamilton AD; Sebti SM
Nat Rev Cancer; 2011 Oct; 11(11):775-91. PubMed ID: 22020205
[TBL] [Abstract][Full Text] [Related]
6. Farnesyl transferase inhibitors.
Li T; Sparano JA
Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
[No Abstract] [Full Text] [Related]
7. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies.
Sebti SM; Hamilton AD
Oncogene; 2000 Dec; 19(56):6584-93. PubMed ID: 11426643
[TBL] [Abstract][Full Text] [Related]
8. Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells.
Tamanoi F; Gau CL; Jiang C; Edamatsu H; Kato-Stankiewicz J
Cell Mol Life Sci; 2001 Oct; 58(11):1636-49. PubMed ID: 11706990
[TBL] [Abstract][Full Text] [Related]
9. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
10. Farnesyltransferase inhibitors and their potential in the treatment of breast carcinoma.
de Bono JS; Tolcher AW; Rowinsky EK
Semin Oncol; 2003 Oct; 30(5 Suppl 16):79-92. PubMed ID: 14613029
[TBL] [Abstract][Full Text] [Related]
11. Farnesyltransferase inhibitors: where are we now?
Tsimberidou AM; Chandhasin C; Kurzrock R
Expert Opin Investig Drugs; 2010 Dec; 19(12):1569-80. PubMed ID: 21083522
[TBL] [Abstract][Full Text] [Related]
12. Preclinical and clinical evaluation of farnesyltransferase inhibitors.
Baum C; Kirschmeier P
Curr Oncol Rep; 2003 Mar; 5(2):99-107. PubMed ID: 12583826
[TBL] [Abstract][Full Text] [Related]
13. [Development of farnesyltransferase inhibitor for anti-cancer drugs].
Takemoto Y; Imoto M
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1713-8. PubMed ID: 18051405
[No Abstract] [Full Text] [Related]
14. An overview on natural farnesyltransferase inhibitors for efficient cancer therapy.
Dai X; Sun Y; Zhang T; Ming Y; Hongwei G
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1027-1044. PubMed ID: 32308053
[TBL] [Abstract][Full Text] [Related]
15. Evolving therapies: farnesyltransferase inhibitors.
Purcell WT; Donehower RC
Curr Oncol Rep; 2002 Jan; 4(1):29-36. PubMed ID: 11734111
[TBL] [Abstract][Full Text] [Related]
16. Farnesyltransferase inhibitors.
Hahn SM; Bernhard E; McKenna WG
Semin Oncol; 2001 Oct; 28(5 Suppl 16):86-93. PubMed ID: 11706400
[TBL] [Abstract][Full Text] [Related]
17. Farnesyl Transferase Inhibitors as Potential Anticancer Agents.
Bagchi S; Rathee P; Jayaprakash V; Banerjee S
Mini Rev Med Chem; 2018; 18(19):1611-1623. PubMed ID: 30068272
[TBL] [Abstract][Full Text] [Related]
18. RAS inhibitors: potential for cancer therapeutics.
Kloog Y; Cox AD
Mol Med Today; 2000 Oct; 6(10):398-402. PubMed ID: 11006529
[TBL] [Abstract][Full Text] [Related]
19. Tailoring Ras-pathway--inhibitor combinations for cancer therapy.
Blum R; Kloog Y
Drug Resist Updat; 2005 Dec; 8(6):369-80. PubMed ID: 16356760
[TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitors and their role in the treatment of multiple myeloma.
Santucci R; Mackley PA; Sebti S; Alsina M
Cancer Control; 2003; 10(5):384-7. PubMed ID: 14581893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
